 | • レポートコード：GIR201112604 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、インスリン様成長因子Iの世界市場を調査対象にし、インスリン様成長因子Iの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（CIGB-845、デュシギツマブ、GM-6、M-610.27、M-630、その他）、用途別分析（アルツハイマー病、乳がん、ハンチントン病、筋ジストロフィー、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Boehringer Ingelheim GmbH、Regulaxis SAS、Genervon Biopharmaceuticals LLC、MedImmune LLC ・メーカー別販売量、売上、市場シェア ・インスリン様成長因子Iの地域別市場分析 ・インスリン様成長因子Iの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・インスリン様成長因子Iのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・インスリン様成長因子Iのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・インスリン様成長因子Iの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・インスリン様成長因子Iの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・インスリン様成長因子Iの種類別市場規模2015-2020：CIGB-845、デュシギツマブ、GM-6、M-610.27、M-630、その他 ・インスリン様成長因子Iの用途別市場規模2015-2020：アルツハイマー病、乳がん、ハンチントン病、筋ジストロフィー、その他 ・インスリン様成長因子Iの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Insulin Like Growth Factor I market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Insulin Like Growth Factor I market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Insulin Like Growth Factor I market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insulin Like Growth Factor I market has been segmented into
CIGB-845
Dusigitumab
GM-6
M-610.27
M-630
Others
By Application, Insulin Like Growth Factor I has been segmented into:
Alzheimer’s Disease
Breast Cancer
Huntington Disease
Muscular Dystrophy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insulin Like Growth Factor I market presented in the report. This section sheds light on the sales growth of different regional and country-level Insulin Like Growth Factor I markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insulin Like Growth Factor I market.
The report offers in-depth assessment of the growth and other aspects of the Insulin Like Growth Factor I market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Insulin Like Growth Factor I Market Share Analysis
Insulin Like Growth Factor I competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insulin Like Growth Factor I sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insulin Like Growth Factor I sales, revenue and market share for each player covered in this report.
The major players covered in Insulin Like Growth Factor I are:
Boehringer Ingelheim GmbH
Regulaxis SAS
Genervon Biopharmaceuticals LLC
MedImmune LLC
Among other players domestic and global, Insulin Like Growth Factor I market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Like Growth Factor I product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Like Growth Factor I, with price, sales, revenue and global market share of Insulin Like Growth Factor I in 2018 and 2019.
Chapter 3, the Insulin Like Growth Factor I competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Like Growth Factor I breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Insulin Like Growth Factor I market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Insulin Like Growth Factor I sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Insulin Like Growth Factor I Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Like Growth Factor I Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CIGB-845
1.2.3 Dusigitumab
1.2.4 GM-6
1.2.5 M-610.27
1.2.6 M-630
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Like Growth Factor I Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alzheimer’s Disease
1.3.3 Breast Cancer
1.3.4 Huntington Disease
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Overview of Global Insulin Like Growth Factor I Market
1.4.1 Global Insulin Like Growth Factor I Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim GmbH
2.1.1 Boehringer Ingelheim GmbH Details
2.1.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim GmbH SWOT Analysis
2.1.4 Boehringer Ingelheim GmbH Product and Services
2.1.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regulaxis SAS
2.2.1 Regulaxis SAS Details
2.2.2 Regulaxis SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regulaxis SAS SWOT Analysis
2.2.4 Regulaxis SAS Product and Services
2.2.5 Regulaxis SAS Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genervon Biopharmaceuticals LLC
2.3.1 Genervon Biopharmaceuticals LLC Details
2.3.2 Genervon Biopharmaceuticals LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genervon Biopharmaceuticals LLC SWOT Analysis
2.3.4 Genervon Biopharmaceuticals LLC Product and Services
2.3.5 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MedImmune LLC
2.4.1 MedImmune LLC Details
2.4.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MedImmune LLC SWOT Analysis
2.4.4 MedImmune LLC Product and Services
2.4.5 MedImmune LLC Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Insulin Like Growth Factor I Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Insulin Like Growth Factor I Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Like Growth Factor I Manufacturer Market Share in 2019
3.3.2 Top 6 Insulin Like Growth Factor I Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Insulin Like Growth Factor I Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Like Growth Factor I Sales and Market Share by Regions (2015-2020)
4.1.2 Global Insulin Like Growth Factor I Revenue and Market Share by Regions (2015-2020)
4.2 North America Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
4.3 Europe Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
4.5 South America Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Insulin Like Growth Factor I Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Like Growth Factor I Sales and Market Share by Country (2015-2020)
5.1.2 North America Insulin Like Growth Factor I Revenue and Market Share by Country (2015-2020)
5.2 United States Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
5.3 Canada Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
5.4 Mexico Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Insulin Like Growth Factor I Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Like Growth Factor I Sales and Market Share by Country (2015-2020)
6.1.2 Europe Insulin Like Growth Factor I Revenue and Market Share by Country (2015-2020)
6.2 Germany Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
6.3 UK Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
6.4 France Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
6.5 Russia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
6.6 Italy Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Insulin Like Growth Factor I Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Insulin Like Growth Factor I Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Insulin Like Growth Factor I Revenue and Market Share by Regions (2015-2020)
7.2 China Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7.3 Japan Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7.4 Korea Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7.5 India Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
7.7 Australia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Insulin Like Growth Factor I Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Like Growth Factor I Sales and Market Share by Country (2015-2020)
8.1.2 South America Insulin Like Growth Factor I Revenue and Market Share by Country (2015-2020)
8.2 Brazil Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
8.3 Argentina Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Insulin Like Growth Factor I Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Insulin Like Growth Factor I Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Insulin Like Growth Factor I Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
9.3 Turkey Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
9.4 Egypt Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
9.5 South Africa Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Insulin Like Growth Factor I Sales and Market Share by Type (2015-2020)
10.2 Global Insulin Like Growth Factor I Revenue and Market Share by Type (2015-2020)
10.3 Global Insulin Like Growth Factor I Price by Type (2015-2020)
11 Global Insulin Like Growth Factor I Market Segment by Application
11.1 Global Insulin Like Growth Factor I Sales Market Share by Application (2015-2020)
11.2 Global Insulin Like Growth Factor I Revenue Market Share by Application (2015-2020)
11.3 Global Insulin Like Growth Factor I Price by Application (2015-2020)
12 Market Forecast
12.1 Global Insulin Like Growth Factor I Sales, Revenue and Growth Rate (2021-2025)
12.2 Insulin Like Growth Factor I Market Forecast by Regions (2021-2025)
12.2.1 North America Insulin Like Growth Factor I Market Forecast (2021-2025)
12.2.2 Europe Insulin Like Growth Factor I Market Forecast (2021-2025)
12.2.3 Asia-Pacific Insulin Like Growth Factor I Market Forecast (2021-2025)
12.2.4 South America Insulin Like Growth Factor I Market Forecast (2021-2025)
12.2.5 Middle East & Africa Insulin Like Growth Factor I Market Forecast (2021-2025)
12.3 Insulin Like Growth Factor I Market Forecast by Type (2021-2025)
12.3.1 Global Insulin Like Growth Factor I Sales Forecast by Type (2021-2025)
12.3.2 Global Insulin Like Growth Factor I Market Share Forecast by Type (2021-2025)
12.4 Insulin Like Growth Factor I Market Forecast by Application (2021-2025)
12.4.1 Global Insulin Like Growth Factor I Sales Forecast by Application (2021-2025)
12.4.2 Global Insulin Like Growth Factor I Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Insulin Like Growth Factor I Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insulin Like Growth Factor I Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Major Business
Table 9. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Total Revenue (USD Million) (2018-2019)
Table 10. Boehringer Ingelheim GmbH SWOT Analysis
Table 11. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product and Services
Table 12. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Regulaxis SAS Basic Information, Manufacturing Base and Competitors
Table 14. Regulaxis SAS Insulin Like Growth Factor I Major Business
Table 15. Regulaxis SAS Insulin Like Growth Factor I Total Revenue (USD Million) (2018-2019)
Table 16. Regulaxis SAS SWOT Analysis
Table 17. Regulaxis SAS Insulin Like Growth Factor I Product and Services
Table 18. Regulaxis SAS Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Genervon Biopharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 20. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Major Business
Table 21. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Total Revenue (USD Million) (2018-2019)
Table 22. Genervon Biopharmaceuticals LLC SWOT Analysis
Table 23. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product and Services
Table 24. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 26. MedImmune LLC Insulin Like Growth Factor I Major Business
Table 27. MedImmune LLC Insulin Like Growth Factor I Total Revenue (USD Million) (2018-2019)
Table 28. MedImmune LLC SWOT Analysis
Table 29. MedImmune LLC Insulin Like Growth Factor I Product and Services
Table 30. MedImmune LLC Insulin Like Growth Factor I Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Insulin Like Growth Factor I Sales by Manufacturer (2018-2019) (K Pcs)
Table 32. Global Insulin Like Growth Factor I Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Insulin Like Growth Factor I Sales by Regions (2015-2020) (K Pcs)
Table 34. Global Insulin Like Growth Factor I Sales Market Share by Regions (2015-2020)
Table 35. Global Insulin Like Growth Factor I Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Insulin Like Growth Factor I Sales by Countries (2015-2020) (K Pcs)
Table 37. North America Insulin Like Growth Factor I Sales Market Share by Countries (2015-2020)
Table 38. North America Insulin Like Growth Factor I Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020)
Table 40. Europe Insulin Like Growth Factor I Sales by Countries (2015-2020) (K Pcs)
Table 41. Europe Insulin Like Growth Factor I Sales Market Share by Countries (2015-2020)
Table 42. Europe Insulin Like Growth Factor I Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Insulin Like Growth Factor I Sales by Regions (2015-2020) (K Pcs)
Table 44. Asia-Pacific Insulin Like Growth Factor I Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Insulin Like Growth Factor I Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Insulin Like Growth Factor I Sales by Countries (2015-2020) (K Pcs)
Table 47. South America Insulin Like Growth Factor I Sales Market Share by Countries (2015-2020)
Table 48. South America Insulin Like Growth Factor I Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Insulin Like Growth Factor I Sales by Countries (2015-2020) (K Pcs)
Table 51. Middle East & Africa Insulin Like Growth Factor I Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Insulin Like Growth Factor I Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020)
Table 54. Global Insulin Like Growth Factor I Sales by Type (2015-2020) (K Pcs)
Table 55. Global Insulin Like Growth Factor I Sales Share by Type (2015-2020)
Table 56. Global Insulin Like Growth Factor I Revenue by Type (2015-2020) (USD Million)
Table 57. Global Insulin Like Growth Factor I Revenue Share by Type (2015-2020)
Table 58. Global Insulin Like Growth Factor I Sales by Application (2015-2020) (K Pcs)
Table 59. Global Insulin Like Growth Factor I Sales Share by Application (2015-2020)
Table 60. Global Insulin Like Growth Factor I Sales Forecast by Regions (2021-2025) (K Pcs)
Table 61. Global Insulin Like Growth Factor I Market Share Forecast by Regions (2021-2025)
Table 62. Global Insulin Like Growth Factor I Sales Forecast by Type (2021-2025) (K Pcs)
Table 63. Global Insulin Like Growth Factor I Market Share Forecast by Type (2021-2025)
Table 64. Global Insulin Like Growth Factor I Sales Forecast by Application (2021-2025)
Table 65. Global Insulin Like Growth Factor I Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Insulin Like Growth Factor I Picture
Figure 2. Global Sales Market Share of Insulin Like Growth Factor I by Type in 2019
Figure 3. CIGB-845 Picture
Figure 4. Dusigitumab Picture
Figure 5. GM-6 Picture
Figure 6. M-610.27 Picture
Figure 7. M-630 Picture
Figure 8. Others Picture
Figure 9. Insulin Like Growth Factor I Sales Market Share by Application in 2018
Figure 10. Alzheimer's Disease Picture
Figure 11. Breast Cancer Picture
Figure 12. Huntington Disease Picture
Figure 13. Muscular Dystrophy Picture
Figure 14. Others Picture
Figure 15. Global Insulin Like Growth Factor I Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Insulin Like Growth Factor I Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Insulin Like Growth Factor I Sales Market Share by Manufacturer in 2019
Figure 36. Global Insulin Like Growth Factor I Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Insulin Like Growth Factor I Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Insulin Like Growth Factor I Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Insulin Like Growth Factor I Revenue Market Share by Regions (2015-2020)
Figure 43. Global Insulin Like Growth Factor I Revenue Market Share by Regions in 2018
Figure 44. North America Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
Figure 45. Europe Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
Figure 47. South America Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Insulin Like Growth Factor I Sales and Growth Rate (2015-2020)
Figure 49. North America Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Insulin Like Growth Factor I Sales Market Share by Countries (2015-2020)
Figure 51. North America Insulin Like Growth Factor I Sales Market Share by Countries in 2018
Figure 52. North America Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Insulin Like Growth Factor I Revenue Market Share by Countries in 2018
Figure 54. United States Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Insulin Like Growth Factor I Revenue Market Share by Countries in 2019
Figure 60. Germany Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Insulin Like Growth Factor I Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Insulin Like Growth Factor I Revenue Market Share by Regions 2019
Figure 68. China Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Insulin Like Growth Factor I Sales Market Share by Countries in 2019
Figure 75. South America Insulin Like Growth Factor I Revenue Market Share by Countries in 2019
Figure 76. Brazil Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Insulin Like Growth Factor I Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Insulin Like Growth Factor I Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Insulin Like Growth Factor I Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Insulin Like Growth Factor I Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Insulin Like Growth Factor I Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Insulin Like Growth Factor I Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Insulin Like Growth Factor I Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Insulin Like Growth Factor I Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Insulin Like Growth Factor I Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Insulin Like Growth Factor I Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
インスリン様成長因子1受容体の世界市場 2020年 Market Overview The global Insulin Like Growth Factor 1 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insulin…- 間質細胞由来因子1の世界市場 2020年 Market Overview The global Stromal Cell Derived Factor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stromal Cell De…
- 核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場 2020年 Market Overview The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in…
- ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 線維芽細胞成長因子2の世界市場 2020年 Market Overview The global Fibroblast Growth Factor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblast Growth …